Skip to main content
Caplight Logo









Stylus Medicine

Stylus Medicine

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.stylusmedicine.com/

Last Round

Series A

Extension

May 13, 2025

Total Funding Raised

$170M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Stylus Medicine is a biotechnology company developing in vivo genetic medicines using engineered recombinase technology and targeted lipid nanoparticle delivery systems.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

in vivo gene therapygenetic medicineCAR-T therapylipid nanoparticlesin vivo editingLNPgene editingnon-viral deliveryengineered recombinasesin vivo CAR-Tgenome integrationbiotech platformnext-gen gene therapyprecision medicinedrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stylus Medicine Comparables

Compare Stylus Medicine with similar companies based on industry and business-model similarity.

Stylus Medicine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NanoCell Therapeutics
90%
CREATE Medicines
88%
Aera Therapeutics
88%

Stylus Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 13, 2025
Series AMay 12, 2025

Stylus Medicine Investors

Notable investors and investment history

Stylus Medicine investors
InvestorRounds
RA Capital ManagementSeries A, Series A Extension
Khosla VenturesSeries A Extension, Series A
Chugai Venture FundSeries A, Series A Extension
Johnson & Johnson Innovation - JJDC, Inc.Series A, Series A Extension
Tachyon VenturesSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 660% MoM, reaching 4.7K.

  • May 13, 2025

    $45M round led by RA Capital Management.

Stylus Medicine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Stylus Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Stylus Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range50
Year Founded2022
Last FundingMay 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?